Literature DB >> 20391294

Disorders of hemostasis associated with chronic kidney disease.

Diana I Jalal1, Michel Chonchol, Giovanni Targher.   

Abstract

Chronic kidney disease (CKD) is a growing global health problem. CKD is typically associated with a prothrombotic tendency in the early stages of the disease, whereas in its more advanced stage, that is, end-stage renal disease, patients suffer from a prothrombotic tendency and, in many cases, a bleeding diathesis. The exact etiology behind the coexistence of these conflicting hemostatic disorders is poorly understood. This review critically appraises studies examining the abnormalities in the hemostasis pathway in patients with CKD, as well as the therapeutic options that are currently available to treat these individuals.

Entities:  

Mesh:

Year:  2010        PMID: 20391294     DOI: 10.1055/s-0030-1248722

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  55 in total

1.  Evaluation of Heparin Anticoagulation Protocols in Post-Renal Transplant Recipients (EHAP-PoRT Study).

Authors:  Joan Chung Yan Ng; Marianna Leung; David Landsberg
Journal:  Can J Hosp Pharm       Date:  2016-04-29

2.  Evaluation of the CRUSADE Risk Score for Predicting Major Bleeding in Patients with Concomitant Kidney Dysfunction and Acute Coronary Syndromes.

Authors:  Marianela Sánchez-Martínez; Pedro J Flores-Blanco; Ángel A López-Cuenca; María J Sánchez-Galián; Miriam Gómez-Molina; Francisco Cambronero-Sánchez; Esther Guerrero-Pérez; Mariano Valdés; James L Januzzi; Sergio Manzano-Fernández
Journal:  Cardiorenal Med       Date:  2017-02-17       Impact factor: 2.041

Review 3.  Mechanisms and consequences of carbamoylation.

Authors:  Sigurd Delanghe; Joris R Delanghe; Reinhart Speeckaert; Wim Van Biesen; Marijn M Speeckaert
Journal:  Nat Rev Nephrol       Date:  2017-07-31       Impact factor: 28.314

4.  Research at the heart of hematology: thrombocytopenias and platelet function disorders.

Authors:  Carlo L Balduini; Federica Melazzini
Journal:  Haematologica       Date:  2017-02       Impact factor: 9.941

Review 5.  Anticoagulation in Cancer Patients: a Summary of Pitfalls to Avoid.

Authors:  Harsh K Patel; Alok A Khorana
Journal:  Curr Oncol Rep       Date:  2019-02-04       Impact factor: 5.075

6.  Targeting STUB1-tissue factor axis normalizes hyperthrombotic uremic phenotype without increasing bleeding risk.

Authors:  Moshe Shashar; Mostafa E Belghasem; Shinobu Matsuura; Joshua Walker; Sean Richards; Faisal Alousi; Keshab Rijal; Vijaya B Kolachalama; Mercedes Balcells; Minami Odagi; Kazuo Nagasawa; Joel M Henderson; Amitabh Gautam; Richard Rushmore; Jean Francis; Daniel Kirchhofer; Kumaran Kolandaivelu; David H Sherr; Elazer R Edelman; Katya Ravid; Vipul C Chitalia
Journal:  Sci Transl Med       Date:  2017-11-22       Impact factor: 17.956

Review 7.  Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction.

Authors:  Tatjana S Potpara; Charles J Ferro; Gregory Y H Lip
Journal:  Nat Rev Nephrol       Date:  2018-03-26       Impact factor: 28.314

8.  Plasma metabolomic profiles in different stages of CKD.

Authors:  Vallabh O Shah; Raymond R Townsend; Harold I Feldman; Kirk L Pappan; Elizabeth Kensicki; David L Vander Jagt
Journal:  Clin J Am Soc Nephrol       Date:  2012-12-06       Impact factor: 8.237

9.  Hepatic and pancreatic resection in patients with end-stage renal disease: a propensity analysis.

Authors:  Andrew S Barbas; Paul J Speicher; Bryan M Clary
Journal:  HPB (Oxford)       Date:  2014-06-16       Impact factor: 3.647

10.  All-trans retinoic acid potentiates cisplatin-induced kidney injury in rats: impact of retinoic acid signaling pathway.

Authors:  Abdelrahman M Elsayed; Tamer M Abdelghany; El-Sayed Akool; Abdel-Aziz H Abdel-Aziz; Mohamed S Abdel-Bakky
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-12-11       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.